Leif E. Pedersen

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. This latest release introduces advanced capabilities that further streamline workflows, improve compliance, and drive innovation across pharmacometrics, modeling, and analytics. With this update, JuliaHub continues to redefine efficiency and impact in pharmaceutical innovation, supporting organizations from preclinical research to regulatory submissions. https://lnkd.in/dwbdB93C

53

Next up at #SapioCon2025 is Rajesh Kumar, Senior Director of Drug Discovery at Schrödinger! 🎤 Rajesh is sharing how Schrödinger has built a data-driven, highly efficient wet lab using the Sapio informatics platform. With real-time tracking of resources, project costs, and performance metrics, they’re accelerating discovery while ensuring long-term data traceability. A great look at how smart lab informatics can drive better decisions, optimize workflows, and keep teams ahead of the curve in drug discovery. 🔬💡 #SapioCon2025 #DrugDiscovery #LabInnovation #DataDrivenScience

53

Give a listen to our very own David Rosner and Kate White Walters on MM+M’s Strategies for Success podcast! In this latest episode, they break down the evolution of #CRM platforms across the life sciences industry, and how the future of customer engagement might look for pharmaceutical companies as they pursue these digital transformations. Check it out here: https://delo.tt/60434rL33

38

In our latest blog, we explore the key considerations for choosing oncology endpoints, their relevance across different trial phases, and how strategic endpoint selection can strengthen study design and support regulatory alignment. Read more: https://lnkd.in/dbETSzqk #LambdaTherapeuticResearch #NovumPharmaceuticalResearch #NovumPRS #LambdaNovum #GlobalCRO #FullServiceCRO #ClinicalTrials #ClinicalResearch #DrugDevelopment #ClinicalDevelopment #OncologyCRO #HematologyCRO #OncologyTrials #OncologyResearch #CancerResearch #Biosimilars #OncologyBiosimilars #EndpointStrategy #ClinicalEndpoints Novum Pharmaceutical Research Services

102

3 Comments

In the latest issue of 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭𝘴, David Ng, Vice President of Global Biometrics at Novotech discusses how the company is helping biotech sponsors turn data into decisions through integrated platforms, role-based dashboards, and continuous monitoring from first patient in through submission. Read the full article https://lnkd.in/dUbmxUtQ Smarter clinical trials require smarter data management. Sponsors now expect real-time visibility, cross-platform integration, and early risk detection—without sacrificing quality. From flexible architectures to on-demand data access, discover what forward-looking data strategy means in 2025. #ClinicalData #Biometrics #DataStrategy

33

Generative AI is reshaping clinical documentation and regulatory submissions, offering faster, more efficient processes. However, its true success lies in addressing critical challenges: data readiness, optimizing content ecosystems, and eliminating inefficiencies in CSR creation. vanessa de langsdorff of Yseop recently collaborated with John April of Eli Lilly and Company and Inger Ødum Nielsen of Novo Nordisk to publish an article in Applied Clinical Trials Magazine, exploring how organizations are overcoming these challenges and maximizing the return on GenAI investments. 📖 Read the full piece here: https://lnkd.in/eD8i4QiG #GenerativeAI #MedicalWriting #RegulatoryAffairs

53

5 Comments

With 5,700 employees across 25 countries, QIAGEN supports global healthcare and life sciences with cutting-edge “Sample to Insight” solutions 🌍 With sensitive data in a cloud-based SAP environment and an ongoing S/4HANA transformation, QIAGEN needed a risk-based SAP Security strategy. The SecurityBridge Platform helped unify fragmented tools and embed cybersecurity into SAP — with immediate impact: faster patching cycles, zero-day response, and a visible rise in SAP security maturity 🚀 We are proud to support QIAGEN in securing its critical SAP landscape and enabling resilience for the future. #CaseStudy #CustomerExperience

29

🚀 Great news! We’ve launched PharmaPendium AI, a generative AI assistant that transforms how regulatory professionals access and apply insights from FDA and EMA documents. Built on our trusted PharmaPendium database, it delivers citation backed responses in seconds, helping teams move faster with greater confidence. Early users report up to 66% time savings per search and review session, saving hundreds of hours each year. 👉 Discover more: https://lnkd.in/ebnJuUxE

77

Is your pharma serialization strategy simply checking the compliance box, or are you leveraging it to fuel growth? Our latest article explores how a strong traceability approach can drive operational efficiency, improve supply chain visibility, and streamline product launches - all while meeting regulatory demands. Discover how to position serialization as a strategic asset in your manufacturing journey at https://lnkd.in/gZH4idtm.

25

1 Comment

📢 FORRS featured in the 2025 CTRM Sourcebook The newly published CTRM Services Sourcebook highlights market-leading expertise in the ETRM/CTRM space – and FORRS is part of it. With many systems and vendors available, the ETRM/CTRM landscape can be difficult to navigate. A clear ETRM strategy is essential to making the right technology decisions and achieving lasting business value. Navigate the complex landscape with us – from assessing market options to defining and implementing the right solution for your needs. 👉Read the full report: https://lnkd.in/eG2Mi-6F #FORRS#CTRM #ETRM #EnergyTrading #CommodityTrading #CTRMStrategy

32

2 Comments

As sales teams and territories grow, so does the need for better data maintenance and accessibility. Learn why one top biopharma moved from a custom MDM tool to #VeevaNetwork and #VeevaOpenData to improve “usability, features, cost, and, importantly, the pace of innovation”: https://lnkd.in/d4vdJViG #pharmaceuticals

40

AI is revolutionizing the pharmaceutical industry, driving efficiency and innovation in drug development. https://ow.ly/EeKj50UlLe7 Our latest industry report, Assessing AI Transformation in Pharma R&D: Current & Future Impact, by Janelle Hart, Managing Editor, Custom Content at Citeline, demonstrates how AI is enhancing operational efficiency, reducing costs, and improving diagnostics. Discover the key insights and see how AI is shaping the future of drug development. Download the report at the link in this post. #Pipeline2Patient #FollowNorstella #Pharma #AI #DrugDevelopment

26

1 Comment

Wayne Walker, SVP, Data Experience at Medidata Solutions, delves into how transparent AI, human insight, and structured data are accelerating clinical trials, reshaping how therapies reach patients and how trust drives innovation in life sciences. Read More:- https://lnkd.in/dx5GamT6 #AiTechPark #AITP #Medidata #Guestinterview

71

In a recent sponsored blog, Veeva Systems reveals that 70% of sites use more than six systems per trial, leading to delays, overload, and burnout. To fix it? They propose a clear path forward: tech that’s Consistent, Connected, and Comprehensive—built to reduce chaos, not add to it. See how Veeva is helping streamline operations and restore focus to research > https://bit.ly/4jBhwXJ #SponsoredContent #Veeva #ResearchSites

25

Manufacturers are facing growing pressure to modernize without ripping and replacing legacy infrastructure, especially in regulated industries like #pharma and life sciences. ✨ The latest Axendia, Inc. briefing highlights how HighByte is meeting this challenge head-on. ✨ Instead of relying on custom code or rigid architectures, the Intelligence Hub enables manufacturers to model, govern, and deliver usable data from disparate systems, making it AI-ready and cloud-optimized. Read the full analysis from Kelly Doering, Mónica V. M., and Sandra Rodriguez, with insights from Torey Penrod-Cambra and Jeffrey Schroeder. 📖 https://lnkd.in/e5Bn7Fp6 #IndustrialData #DigitalTransformation #DataOps

69

1 Comment

Ready to elevate consulting results with domain-driven data expertise? Read our latest blog: Why consulting firms need strategic scientific informatics partners 🔗 https://hubs.la/Q03vTYrz0 With genome sequencing expected to hit 40 exabytes/year by 2025, clients demand AI-ready insights from genomics, proteomics, and clinical data. Building in-house analytics is costly and complex. Partnering with scientific informatics experts offers scalable, compliant solutions—NGS pipelines, multi-omics integration, biomarker discovery, and domain expertise—enabling faster, deeper insights without heavy investment. Elevate your consulting impact—read the full blog to gain the strategic edge. #ScientificInformatics #Consulting #Genomics #LifeSciences #AI #Excelra

29

https://ow.ly/9XXZ50VEaQK Pharma companies are increasingly turning to real-world data to answer their commercial business questions, but not all realize that unstructured EMR data is the unsung hero of most queries. In BioPharma Dive, Norstella's Ilan Behm explains how AI can turn unstructured clinical notes into usable insights.

14